10-May-2019 | D | The Register of Members and Share Transfer Books will remain closed from Saturday, July 27, 2019 to Friday, August 2, 2019, both days inclusive for the purpose of Dividend and Annual General Meeting.
The Board also recommended a Dividend at the rate of Rs. 105/- per equity share of Rs. 10 each. The Dividend, if approved by the shareholders in the ensuing Annual General Meeting scheduled to be held on Friday, August 2, 2019, will be paid to those members whose names appear in the Company's Register of Members and to those persons whose names appear as Beneficial owners as per the details to be furnished by National Securities Depository Limited and Central Depository Services (India) Ltd. as at the close of business hours on Friday, July 26, 2019.
The 60th Annual General Meeting of the members of the Company will be held on Friday, August 2, 2019 at 9.30 a.m. at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha 147 201 (Punjab
| 25-Jul-2019 | |
11-May-2018 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2018, inter alia, has recommended a Dividend at the rate of Rs. 75/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 07, 2018. | 31-Jul-2018 | |
11-May-2017 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2017, inter alia, has recommended a Dividend at the rate of Rs. 70/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 08, 2017. | 02-Aug-2017 | |
17-May-2016 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 17, 2016, inter alia, has recommended a Dividend at the rate of Rs. 70/- per equity share of Rs. 10 each.
The dividend shall be paid to the entitled Members on or before September 04, 2016. | 26-Jul-2016 | |
08-May-2015 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2015, inter alia, has recommended a Dividend at the rate of Rs. 55/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 05, 2015. | 27-Jul-2015 | |
09-May-2014 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2014, inter alia, has recommended a Dividend at the rate of Rs. 45/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 05, 2014. | 28-Jul-2014 | |
15-Feb-2013 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 15, 2013, inter alia, has recommended a Dividend at the rate of Rs. 45 per equity share of Rs. 10 each. | 19-Mar-2013 | |
06-Feb-2012 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 06, 2012, inter alia, has recommended a Dividend at the rate of Rs. 35/- per equity share of Rs. 10 each. | 09-Mar-2012 | |
02-Feb-2011 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 02, 2011, inter alia, has recommended a Dividend at the rate of Rs. 50 per equity share of Rs. 10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company). | 11-Mar-2011 | |
02-Feb-2011 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 02, 2011, inter alia, has recommended a Dividend at the rate of Rs. 50 per equity share of Rs. 10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company). | 11-Mar-2011 | |
25-Jan-2010 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 25, 2010, inter alia, has recommended a Final Dividend at the rate of Rs. 18 per equity share of Rs. 10 each. | 09-Apr-2010 | |
27-Jan-2009 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 27, 2009, inter alia, has recommended a Final Dividend at the rate of Rs 5 per equity share of Rs 10 each. | 13-Apr-2009 | |
24-Oct-2008 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 24, 2008, inter alia, has declared an interim dividend of Rs 10/- per equity share for the year ending December 31, 2008. | 29-Oct-2008 | |
23-Oct-2007 | D | GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 23, 2007, inter alia, has declared an interim dividend of Rs 12.00 per equity share for the year ending December 31, 2007. | 29-Oct-2007 | |
23-Jun-2021 | BC | Trading Members of the Exchange are hereby informed that the under mentioned scrip code of the Company which has been suspended due to record date fixed for Corporate Action of Amalgamation shall be | 24-Jun-2021 | |
03-Apr-2020 | BC | Amalgamation | 17-Apr-2020 | |
08-Apr-2020 | BC | Sub: Suspension of trading in equity shares -GlaxoSmithKline Consumer Healthcare LimitedIn pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Pa | 16-Apr-2020 | |
13-Mar-2020 | BC | Pursuant to Reg 30(7) of SEBI LODR, further to our communication dated Feb 26, 2020, plS see enclosed a copy of the order dated Feb 26, 2020 and clarification dated Feb 28, 2020 alongwith order as pe | 01-Apr-2020 | |
13-Jan-2020 | BC | GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2020 ,inter alia, to consider and approve Pursuant to Regulati | 06-Feb-2020 | |